Tier IPCSK9 monoclonal
PCSK9 mAb (alirocumab)
PCSK9 monoclonal
Recommended Dose
75 mg q2w
Purity Standard
99.0% — sourced from Praluent
Clinical Evidence
220 indexed trials · Tier I
Hallmarks Addressed
Hallmarks 10
PCSK9 monoclonal
75 mg q2w
99.0% — sourced from Praluent
220 indexed trials · Tier I
Hallmarks 10